Investigating Systematic Misclassification of Central Line–Associated Bloodstream Infection (CLABSI) to Secondary Bloodstream Infection During Health Care–Associated Infection Reporting-Reference-Cited by-同舟云学术

Investigating Systematic Misclassification of Central Line–Associated Bloodstream Infection (CLABSI) to Secondary Bloodstream Infection During Health Care–Associated Infection Reporting

Published:2012-06-07 Issue:1 Volume:28 Page:56-59
ISSN:1062-8606
Container-title:American Journal of Medical Quality
language:en
Short-container-title:Am J Med Qual

Author:

Thompson Nicola D.¹,Yeh Lan Lan L.²,Magill Shelley S.¹,Ostroff Stephen M.²,Fridkin Scott K.¹

Affiliation:

1. Centers for Disease Control and Prevention, Atlanta, GA

2. Pennsylvania Department of Health, Harrisburg, PA

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Health Policy

Link

http://journals.sagepub.com/doi/pdf/10.1177/1062860612442565

Reference6 articles.

1. Meaningful measure of performance: A foundation built on valid, reproducible findings from surveillance of health care-associated infections

2. Methicillin-Resistant Staphylococcus aureus Central Line–Associated Bloodstream Infections in US Intensive Care Units, 1997-2007

3. Surveillance Bias in Outcomes Reporting

4. Data Quality Bias

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The applicability of the central line‐associated bloodstream infection (CLABSI) criteria for the evaluation of bacteremia episodes in pediatric oncology patients;European Journal of Haematology;2024-01-31

2. Institutional factors associated with the incidence rates of central line-associated bloodstream infection in California community hospitals;PLOS ONE;2022-09-30

3. The deterrent effect of tort law: Evidence from medical malpractice reform;Journal of Health Economics;2022-07

4. ESBL production and carbapenem resistance increased the secondary bloodstream infection rates in intensive care units in Turkey, 2014-2019;GMS HYG INFECT CONTR;2022

5. Real-world evidence for coverage decisions: opportunities and challenges;Journal of Comparative Effectiveness Research;2018-12